Is it necessary to hold statin (HMG-CoA reductase inhibitor) therapy when taking terbinafine (antifungal medication)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Statin Therapy Can Be Continued When Taking Terbinafine

It is not necessary to hold statin therapy when taking terbinafine as terbinafine has minimal drug-drug interactions with statins and does not significantly inhibit the cytochrome P450 3A4 enzyme that metabolizes most statins. 1, 2

Drug Interaction Profile of Terbinafine

  • Terbinafine is an oral antifungal agent commonly used for treating onychomycosis (fungal nail infections) 1
  • Unlike azole antifungals (such as itraconazole), terbinafine has minimal drug-drug interactions and is generally well-tolerated in patients taking multiple medications 2
  • Terbinafine primarily affects the cytochrome P450 2D6 isoenzyme, not the CYP3A4 enzyme that metabolizes most statins 1, 3
  • No contraindications exist for the concurrent use of terbinafine and statins 2

Contrast with Other Antifungal Medications

  • Azole antifungals (itraconazole, fluconazole) are potent inhibitors of CYP3A4 and can significantly increase statin levels, potentially causing myopathy or rhabdomyolysis 4, 5
  • A case report documented statin-associated rhabdomyolysis triggered by itraconazole (not terbinafine) due to CYP3A4 inhibition 4
  • When antifungal treatment is needed for patients on statins, terbinafine is actually preferred over azole antifungals due to its favorable drug interaction profile 4, 2

Monitoring Recommendations

  • While no specific interaction exists between statins and terbinafine, general monitoring for statin therapy should continue as usual 1:
    • Evaluate muscle symptoms and CK levels at baseline and during follow-up visits
    • Monitor for headache, dyspepsia, and other common statin side effects
    • Check liver function tests (ALT/AST) initially, after 12 weeks, and then annually

Special Considerations

  • Patients with risk factors for statin-associated myopathy should be monitored more carefully regardless of concurrent medications 1:
    • Advanced age (especially >80 years)
    • Small body frame and frailty
    • Multisystem disease (especially chronic renal insufficiency)
    • Multiple medications
    • Perioperative periods

Clinical Decision Making

  • Terbinafine is actually the preferred antifungal agent for patients on statin therapy due to its minimal drug interaction potential 2
  • In a large postmarketing surveillance study with over 25,000 patients (42.8% taking concomitant medications), terbinafine revealed no new drug-drug interactions 2
  • Some combinations of statins and terbinafine have even shown synergistic effects against dermatophytes in laboratory studies, potentially enhancing antifungal efficacy 6

In conclusion, unlike azole antifungals which require statin dose adjustment or temporary discontinuation, terbinafine can be safely administered with statins without the need to hold statin therapy, making it the preferred antifungal option for patients on statins.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Drug interactions of the newer oral antifungal agents.

The British journal of dermatology, 1999

Research

[Terbinafine : Relevant drug interactions and their management].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2016

Research

Rhabdomyolysis and HMG-CoA reductase inhibitors.

The Annals of pharmacotherapy, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.